Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prescriptions hors-AMM : comment en pratique les identifier, les encadrer, informer et les suivre ?
Le Jeunne C, Billon N, Dandon A; les participants à la table ronde N° 3 de Giens XXVIII :; Berdaï D, Adgibi Y, Bergmann JF, Bordet R, Carpentier A, Cohn E, Courcier S, Girault D, Goni S, Jolliet P, Liard F, Prot-Labarthe S, Simon T, Vernotte C, Westerloppe J. Le Jeunne C, et al. Among authors: bordet r. Therapie. 2013 Jul-Aug;68(4):225-31. doi: 10.2515/therapie/2013039. Therapie. 2013. PMID: 27392725 French. No abstract available.
Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
Le Jeunne C, Billon N, Dandon A; participants of round table N° 3 of Giens XXVIII (th); Berdaï D, Adgibi Y, Bergmann JF, Bordet R, Carpentier A, Cohn E, Courcier S, Girault D, Goni S, Jolliet P, Liard F, Prot-Labarthe S, Simon T, Vernotte C, Westerloppe J. Le Jeunne C, et al. Among authors: bordet r. Therapie. 2013 Jul-Aug;68(4):225-39. doi: 10.2515/therapie/2013041. Epub 2013 Aug 28. Therapie. 2013. PMID: 23981260 Free article. English, French.
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Sablonniere B, Azulay JP, Tison F, Rascol O, Vidailhet M, Destée A, Bloem BR, Bordet R, Devos D; Parkgait-II study group. Moreau C, et al. Among authors: bordet r. Lancet Neurol. 2012 Jul;11(7):589-96. doi: 10.1016/S1474-4422(12)70106-0. Epub 2012 Jun 1. Lancet Neurol. 2012. PMID: 22658702 Clinical Trial.
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.
Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group. Moreau C, et al. Among authors: bordet r. Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23. Brain. 2015. PMID: 25805645 Free PMC article. Clinical Trial.
Targeting chelatable iron as a therapeutic modality in Parkinson's disease.
Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, Jonneaux A, Ryckewaert G, Garçon G, Rouaix N, Duhamel A, Jissendi P, Dujardin K, Auger F, Ravasi L, Hopes L, Grolez G, Firdaus W, Sablonnière B, Strubi-Vuillaume I, Zahr N, Destée A, Corvol JC, Pöltl D, Leist M, Rose C, Defebvre L, Marchetti P, Cabantchik ZI, Bordet R. Devos D, et al. Among authors: bordet r. Antioxid Redox Signal. 2014 Jul 10;21(2):195-210. doi: 10.1089/ars.2013.5593. Epub 2014 Feb 6. Antioxid Redox Signal. 2014. PMID: 24251381 Free PMC article. Clinical Trial.
Medical pharmacology: from review to planning.
Bordet R, Jolliet P, Jaillon P. Bordet R, et al. Therapie. 2006 Nov-Dec;61(6):457-61. doi: 10.2515/therapie:2006083. Therapie. 2006. PMID: 17348602 Review.
How has the future investment program stimulated research and innovation in health?
Bordet R, Dantonel JC, Vacaresse E, Le Jeunne C, Benhabiles N, Beretz A, Boitard C, Debette S, Duluc G, Froguel P, Garbil B, Lyonnet S, Mahfoudi A, Marquet P, Mouthon F, Rascol O, Richard V, Simon E, Varoqueaux N, Watier H, Zins M. Bordet R, et al. Therapie. 2022 Jan-Feb;77(1):19-24. doi: 10.1016/j.therap.2022.01.009. Epub 2022 Jan 18. Therapie. 2022. PMID: 35148896
420 results